1. Health Canada: potential link between ketamine use and liver damage

   News item 27 June 2020 Pages: 1 - 1

2. Japan's PMDA revises package inserts for memantine, bevacizumab

   News item 27 June 2020 Pages: 2 - 2

3. New potential interaction with emergency COVID-19 medicine remdesivir

   News item 27 June 2020 Pages: 3 - 3

4. SFDA: importance of INR monitoring when switching warfarin brands

   News item 27 June 2020 Pages: 4 - 4

5. Computerised tool reduces polypharmacy but not AEs in elderly

   Clinical study 27 June 2020 Pages: 5 - 5

6. Disproportionality analysis of subgroups in VigiBase uncovers signals

   Clinical study 27 June 2020 Pages: 6 - 6

7. Non-ocular haemorrhage with intravitreal aflibercept vs ranibizumab

   Clinical study 27 June 2020 Pages: 7 - 7

8. Psychotropic-related severe weight gain

   Clinical study 27 June 2020 Pages: 8 - 8

9. Reframing side effect information in patient information leaflets

   Clinical study 27 June 2020 Pages: 9 - 9

10. Risk of Kawasaki disease with PCV or MenB vaccines in England

    Clinical study 27 June 2020 Pages: 10 - 10

11. Safety profile of JE-CV in Taiwan

    Clinical study 27 June 2020 Pages: 11 - 11

12. SSRI treatment in young adults increases risk of violent crimes

    Clinical study 27 June 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 27 June 2020 Pages: 13 - 13

14. Acetylcysteine

    Case report 27 June 2020 Pages: 14 - 14

15. Adalimumab

    Case report 27 June 2020 Pages: 15 - 15

16. Adalimumab/infliximab/rituximab

    Case report 27 June 2020 Pages: 16 - 16

17. Adenosine

    Case report 27 June 2020 Pages: 17 - 17

18. Afatinib/gefitinib/osimertinib

    Case report 27 June 2020 Pages: 18 - 18

19. Aflibercept

    Case report 27 June 2020 Pages: 19 - 19

20. Alcohol

    Case report 27 June 2020 Pages: 20 - 20

21. Allopurinol/mercaptopurine

    Case report 27 June 2020 Pages: 21 - 21

22. Alteplase

    Case report 27 June 2020 Pages: 22 - 22

23. Amikacin/amoxicillin/clavulanic-acid/clindamycin

    Case report 27 June 2020 Pages: 23 - 23

24. Amiodarone/norepinephrine

    Case report 27 June 2020 Pages: 24 - 24

25. Amoxicillin

    Case report 27 June 2020 Pages: 25 - 25

26. Amphotericin-B liposomal/prednisone/voriconazole

    Case report 27 June 2020 Pages: 26 - 26

27. Anakinra

    Case report 27 June 2020 Pages: 27 - 27

28. Anlotinib

    Case report 27 June 2020 Pages: 28 - 28

29. Antibacterials/isavuconazole/voriconazole

    Case report 27 June 2020 Pages: 29 - 29

30. Antiepileptic drugs

    Case report 27 June 2020 Pages: 30 - 30

31. Antineoplastics

    Case report 27 June 2020 Pages: 31 - 31

32. Antineoplastics

    Case report 27 June 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 27 June 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 27 June 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 27 June 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 27 June 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 27 June 2020 Pages: 37 - 37

38. Antiparkinsonians

    Case report 27 June 2020 Pages: 38 - 38

39. Antiretrovirals

    Case report 27 June 2020 Pages: 39 - 39

40. Antiretrovirals/testosterone

    Case report 27 June 2020 Pages: 40 - 40

41. Antithymocyte globulin

    Case report 27 June 2020 Pages: 41 - 41

42. Antituberculars/levofloxacin

    Case report 27 June 2020 Pages: 42 - 42

43. Apixaban

    Case report 27 June 2020 Pages: 43 - 43

44. Apixaban/heparin/plasminogen activators

    Case report 27 June 2020 Pages: 44 - 44

45. Aspirin/capecitabine/temozolomide

    Case report 27 June 2020 Pages: 45 - 45

46. Atomoxetine overdose

    Case report 27 June 2020 Pages: 46 - 46

47. Azathioprine/mycophenolate mofetil/rituximab

    Case report 27 June 2020 Pages: 47 - 48

48. Baclofen/myoclonus/tramadol

    Case report 27 June 2020 Pages: 48 - 48

49. Bevacizumab

    Case report 27 June 2020 Pages: 49 - 49

50. Bevacizumab/capecitabine

    Case report 27 June 2020 Pages: 50 - 50